This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Despite regulatory progress and new market access, XRP has struggled to break out in 2026. This piece analyzes whethe...
A surge of headlines about aliens and the Catholic Church is reshaping how investors think about religion, charity, a...
A software CEO credits AI with tripling her productivity, then her daughter’s Dartmouth essay reveals a personal pers...
Lockheed Martin reports a record backlog near $194 billion, underscoring long-term demand for flagship programs and a...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Tensions with Iran are driving a puzzling market mix: gold retreats while equities slip only modestly, hinting at a b...
A new, concentrated fund is delivering outsized tech gains fueled by Nvidia, Micron and TSMC. The fund’s early-2026 s...
A rare ‘super’ niño looking could intensify weather extremes this year, impacting crops, energy costs, and budgets. H...
Investors eye a potential SpaceX IPO as a catalyst for sweeping changes in billionaire wealth dynamics. If priced hig...
Bloom Energy faces a bearish price prediction as momentum cools and AI-driven demand faces headwinds, suggesting sign...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...